Receiver operating characteristic (ROC) analysis and multivariate Cox analysis were conducted to clarify the diagnostic and prognostic efficacy of LIFR‐K620 acetylation in PCa, the results of which indicated that LIFR‐K620 acetylation is a potential biomarker that predicts PCa patient prognosis (Figure S1D, Tables S3 and S4). This evidence concerns the gene LIFR and posterior cortical atrophy.